Chemomab Therapeutics (CMMB) Cash from Investing Activities (QoQ) (2018 - 2023)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Chemomab Therapeutics | 959.23 Mn | 948.86 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -56.80% |
| Sep 30, 2023 | 193.51% |
| Jun 30, 2023 | -129.57% |
| Mar 31, 2023 | 54.35% |
| Dec 31, 2022 | 53.93% |
| Sep 30, 2022 | 251.71% |
| Jun 30, 2022 | -27.50% |
| Mar 31, 2022 | 112.16% |
| Dec 31, 2021 | -291.62% |
| Sep 30, 2021 | 75.73% |
| Jun 30, 2021 | -1,030,050.00% |
| Mar 31, 2021 | 33.33% |
| Dec 31, 2020 | 85.00% |
| Sep 30, 2020 | 31.03% |
| Jun 30, 2020 | -190.00% |
| Mar 31, 2020 | -103.98% |
| Dec 31, 2019 | 198.43% |
| Sep 30, 2019 | -1,493.75% |
| Jun 30, 2019 | 78.67% |
| Mar 31, 2019 | -188.46% |
| Dec 31, 2018 | 83.12% |
| Sep 30, 2018 | -185.19% |
| Jun 30, 2018 | 48.08% |
| Mar 31, 2018 | -1,200.00% |